3D PRINTING OF PHARMACEUTICALS –A POTENTIAL TECHNOLOGY IN DEVELOPING PERSONALIZED MEDICINE
Journal Title: Asian Journal Of Pharmaceutical Research and Development - Year 2018, Vol 6, Issue 3
Abstract
The 3D PRINTING technology has caught the attention of medical devices industry and pharmaceutical industry due to its applications on various platform in health care industry. Even though this technology exists for a long time it is of public interest highly now due to the approval of 3-D printed tablet and other medical devices and also with the advent of USFDA’s guidance on technical considerations specific to devices using additive manufacturing which encompasses 3-dimensional (3D) printing has triggered many thoughts about this technology which needs to be considered for successful delivery of intended product. This paper presents regulatory agencies expectations, limitations, problems in establishing such setups for production of drug products, advantages, disadvantages, applications, methods and associated risks involved in manufacturing. It also provides the comprehensive review of the current status of research and development on this platform.
Authors and Affiliations
Preethy Ani Jose
Keywords
Related Articles
- EP ID EP499288
- DOI 10.22270/ajprd.v6i3.375
- Views 116
- Downloads 0
REGULATORY PERSPECTIVE OF BIOSIMILARS IN INDIA
Biosimilar drugs are follow-on versions of original biopharmaceutical medicines. They are independently developed after the patent protecting the original product has expired. Biosimilars are designed to target specific...
FORMULATION AND EVALUATION OF FAST DISSOLVING ORAL FILM OF ANTI-ALLERGIC DRUG
The aim of present work was the development of fast dissolving oral film of Loratadine to overcome the limitations of currentroutes of administration, to provide immediate action and increase the patient compliance. To i...
KNOWLEDGE AND PRESCRIBING PRACTICE OF AMBULATORY CARE PHYSICIANS ABOUT DISTINCT ANTIBIOTICS TOWARDS TRIVIAL RESPIRATORY TRACT INFECTED PATIENTS: STRATEGIES FOR OPTIMAL OUTCOMES AND MINIMIZED RESISTANCE
According to World Health Organization (WHO), respiratory tract infections kill 2.6 million children every year worldwide so, it is recognized as the leading cause of morbidity and mortality. Respiratory tract diseases a...
Liquisolid Technology: A Novel Concept
Most of the drugs that have been invented are BCS Class II. This technique of delivering drugs is suitable mostly for lipophilic drugs and poorly water soluble drugs and enhance the immediate or sustain release formulati...
SCREENING PHYTOCHEMICAL ANDANTI-METHICILLIN RESISTANT (MRSA)ACTIVITY OF 70 % ETHANOLIC EXTRACT FROM THE STEM BARK OF ALBIZIA LEBBECK(L.) BENTH.(FABACEAE)
The emergence of multi-drug resistant strains and limitations of present antimicrobial drugs have led to continuous search for natural products as curative agents for Anti-methicillin resistantinfe...